SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD
SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Pulmonology Consultation — Phillis Wheatley
| Patient | Phillis Wheatley |
|---|
| Date of birth | 2006-07-01 |
|---|
| Identifiers | MRN HR-EN015-SYN; SSN (made up) 000-15-3360 |
|---|
| Document date | 2026-02-23 |
|---|
| Author | Gideon Fairbanks-Mensah, MD |
|---|
| Custodian | St. Posthumous Health Center |
|---|
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Reason for Referral
Three months of winter wheeze, cough and breathlessness in a 19-year-old never-smoking woman, born in West Africa, who has been called frail and asthmatic since childhood but has never had lung function testing or treatment. Please confirm or refute asthma with spirometry before and after bronchodilator and FeNO, help exclude other chest disease, and advise on treatment, including preparation for a long sea journey she may make in the spring. [S]
Urgency: Within two weeks. [S]
Questions for the consultant:
- Does she have asthma, and have tuberculosis and other chest disease been excluded?
- How should her lung function be interpreted, given the move to race-neutral reference equations?
- Which GINA track and step do you recommend, and what reliever?
- What is her inflammatory phenotype, and which triggers matter most?
- How should she prepare for a long sea journey and months away from her clinic?
- What should she know about her asthma treatment if she becomes pregnant in the future?
History of Present Illness
Miss Wheatley, 19, is seen at the request of Dr. Hartley-Okonkwo for three months of winter wheeze, cough and breathlessness, on a background of a weak chest since childhood that was called asthma but never tested. Symptoms come on three or four days a week, with waking about twice a month, and are brought on by cold wind, kitchen and fireplace smoke, and colds. She has never smoked, has never had an inhaler, and has never needed emergency care for her breathing. She may travel by sea in the spring. She was seen alone and gave her own consent. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
- Phillis Wheatley was born in West Africa, probably in the Senegambia region (present-day Senegal and the Gambia), about 1753 or 1754. Nothing is known of her early life before she was kidnapped and trafficked as a child. [D]
- In 1761 the child arrived in Boston aboard the slave ship Phillis (on 11 July, by one scholarly chronology) and was bought by the Boston merchant John Wheatley and his wife Susanna (or Susannah), in whose household she was enslaved as a domestic servant and companion. She was named Phillis after the ship and Wheatley after the family. The family judged her to be about seven because she was shedding her front teeth. [D]
- When she was bought in 1761 she was described as a slender, frail child, "evidently suffering from a change of climate"; the slave ship's captain is said to have sold her cheaply because he believed she was dying. One reference work describes her as "the frail, asthmatic child" and says she remained small and delicate. [D]
- In the Wheatley household she was taught to read and write and within about sixteen months could read the Bible; she went on to read Greek and Latin classics and British literature. Her first known poem was published in the Newport Mercury in December 1767, and her elegy on the evangelist George Whitefield, published in 1770, brought her wide renown. [D]
- Proposals to publish a volume of her poems in Boston in 1772 found too few subscribers, and the volume was instead prepared for publication in London with the support of Selina Hastings, Countess of Huntingdon. [D]
8 later historical claims are omitted because they describe events after the index age. See the teaching note.
Allergies and Intolerances
| Allergy | Reaction | Status | Evidence |
|---|
| No known allergy | | active | S |
Medications
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|
| Budesonide-formoterol 160/4.5 mcg inhaler as needed only (GINA track 1, step 2, anti-inflammatory reliever): one inhalation whenever needed for symptoms or before exercise in the cold, no more than 12 inhalations a day | One inhalation as needed | Respiratory tract route | 2026-02-23 to 2026-09-21 | completed | S |
Problems
| Problem | Clinical status | Verification | Code | Provenance |
| Wheeze, cough and breathlessness this winter, for about three months: symptoms on three or four days a week, waking with cough and a tight chest about twice a month, breathless climbing the hill streets in cold air; worse with cold wind, kitchen and fireplace smoke, and colds; called a weak chest and asthma since childhood but never tested or treated. Asthma to be confirmed with spirometry before and after bronchodilator and FeNO | resolved | confirmed |
R06.2 | S — Synthetic presenting problem anchored to her documented frail, asthmatic childhood. Superseded by the diagnosis at the second visit. |
| Asthma, confirmed, mild persistent: variable airflow obstruction (FEV1/FVC 0.72, below the lower limit of normal, rising to 0.80 after bronchodilator; FEV1 2.24 L, 83 percent predicted, rising 330 mL or 15 percent); type 2 inflammation (FeNO 38 ppb, blood eosinophils 0.38 x10^3/uL, total IgE 165, house dust mite sensitization); tuberculosis infection test negative and chest X-ray clear. Triggers: cold air, kitchen and fireplace smoke, colds | active | confirmed |
J45.30 | S — Synthetic modern confirmation linked to her documented frail, asthmatic childhood and her own later descriptions of asthma. |
Physical Exam
Vital signs recorded on 2026-02-23; see the referring visit's Vital Signs section. [S]
| System | Finding |
|---|
| General | Slight and composed, speaking in full sentences; oxygen saturation 98 percent |
| Nose and throat | Nasal mucosa normal; no polyps |
| Respiratory | Faint expiratory wheeze on forced expiration; no crackles; no clubbing |
| Cardiovascular | Regular rhythm; no murmur |
Results
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
| 2026-02-23 | FEV1 --pre bronchodilation | 2.24 | L | Lower limit of normal; predicted 2.70 L; lower limit of normal 2.17 L (GLI Global race-neutral equations) | Normal | S |
| 2026-02-23 | FEV1 --post bronchodilation | 2.57 | L | Lower limit of normal; predicted 2.70 L; lower limit of normal 2.17 L (GLI Global race-neutral equations) | Normal | S |
| 2026-02-23 | FEV1 measured/predicted | 83 | % | GLI Global race-neutral equations | Normal | S |
| 2026-02-23 | FEV1/FVC | 0.72 | {ratio} | Lower limit of normal for her age (GLI Global) | Low | S |
| 2026-02-23 | FEV1/FVC --post bronchodilation | 0.8 | {ratio} | Lower limit of normal for her age (GLI Global) | Normal | S |
| 2026-02-23 | Fractional concentration of exhaled nitric oxide | 38 | [ppb] | Above 50 ppb high; 25 to 50 intermediate (ATS) | High | S |
| 2026-02-23 | IgE [Units/volume] in Serum or Plasma | 165 | [IU]/mL | <=100 [IU]/mL | High | S |
| 2026-02-23 | Total score [ACT] | 16 | {score} | | | S |
Assessment
- Asthma, confirmed, mild persistent, with type 2 inflammation (J45.30). Question 1: this is asthma. The FEV1/FVC below the lower limit of normal that rises to normal after albuterol, with a 330 mL (15 percent) rise in FEV1, shows variable, reversible airflow obstruction. Tuberculosis infection is excluded by the negative interferon-gamma release assay, and the clear chest X-ray argues against bronchiectasis or scarring; nothing in her history suggests inducible laryngeal obstruction. Question 2: with race-neutral GLI Global equations her FEV1 is 83 percent of predicted; older race-based equations would have set a lower predicted value and could have made her obstruction look like none at all. Question 4: FeNO 38 ppb, blood eosinophils of 0.38 and sensitization to house dust mite show type 2 inflammation, which responds well to inhaled corticosteroid. Her most important triggers are cold air, smoke from cooking and fires, and colds; dust mite matters in the bedroom. [S]
- Wheeze, cough and breathlessness (R06.2). Explained by asthma. [S]
Data reviewed: Dr. Hartley-Okonkwo's intake note and results: chest X-ray clear; blood eosinophils 0.38; interferon-gamma release assay negative; urine pregnancy test negative; Asthma Control Test 15. This morning, in our laboratory, with GLI Global race-neutral equations: FEV1 2.24 L (83 percent predicted) before and 2.57 L after albuterol 400 mcg (+330 mL, +15 percent); FEV1/FVC 0.72 before, below the lower limit of normal of 0.75, and 0.80 after; FeNO 38 ppb. Total IgE 165 IU/mL; specific IgE positive to house dust mite and negative to cat and mold. [S]
Plan of Treatment
- Question 3: GINA track 1, step 2: budesonide-formoterol 160/4.5 mcg, one inhalation as needed for symptoms and before going out in the cold, up to 12 a day; no albuterol-only reliever. This halves the risk of severe exacerbations compared with albuterol alone and suits her symptoms on several days a week. [S]
- Teach technique with a spacer and check it at every visit; review six weeks after starting and within a week of any exacerbation; step up to maintenance and reliever (step 3) if control is not reached or after an exacerbation, and step back down when she is well. [S]
- A written action plan with peak flow zones, and a two-week diary to set her personal best. [S]
- Triggers: ventilate the kitchen and avoid fireplace smoke; a scarf over the mouth in cold wind; mite-proof bedding covers. [S]
- Question 5: for the journey, two inhalers and the spacer, zones set from her personal best, a standby five-day course of prednisone with clear start rules for when care is far away, treatment for seasickness, an aired cabin away from smoke, and a printed summary; spirometry and FeNO again after her return. [S]
- Question 6: well-controlled asthma is safe in pregnancy and uncontrolled asthma is the main risk; budesonide is the inhaled steroid with the most reassuring pregnancy data, and her treatment should continue, not stop, if she becomes pregnant; plan a review before and during any pregnancy. [S]
- Vaccines: influenza and COVID-19 each season, and PCV20 once, as an adult with asthma. [S]
- Discussed with Dr. Hartley-Okonkwo the same day. The results were explained to Miss Wheatley alone, in plain words, with a printed copy; she asked how the reference equations work and why it matters. She decides who else may receive this note. [S]
- Follow-up: Pulmonology review after the repeat spirometry on her return, or sooner if an exacerbation occurs or control is not reached; Dr. Hartley-Okonkwo continues primary care and shares the monitoring. [S]